1 – 10 of 87
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
Fransson, Per ; Nilsson, Per LU
; Gunnlaugsson, Adalsteinn
LU
; Beckman, Lars
; Tavelin, Björn
; Norman, David
; Thellenberg-Karlsson, Camilla
; Hoyer, Morten
; Lagerlund, Magnus
and Kindblom, Jon
, et al.
(2021)
In The Lancet Oncology
22(2).
p.235-245
Mark
- 2020
-
Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer : A Dose-Response Study
Rasmusson, Elisabeth LU ; Nilsson, Per LU
; Kjellén, Elisabeth
LU
and Gunnlaugsson, Adalsteinn
LU
(2020)
In Advances in Radiation Oncology
Mark
-
Altered fractionation diminishes importance of tumor volume in oropharyngeal cancer : Subgroup analysis of ARTSCAN-trial
Adrian, Gabriel LU
; Gebre-Medhin, Maria
LU
; Kjellén, Elisabeth
LU
; Wieslander, Elinore
LU
; Zackrisson, Björn
and Nilsson, Per
LU
(2020)
In Head and Neck
42(8).
p.2099-2105
Mark
-
PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study
Gunnlaugsson, Adalsteinn LU ; Kjellén, Elisabeth LU ; Bratt, Ola LU ; Ahlgren, Göran LU ; Johannesson, Vilberg LU ; Blom, René LU and Nilsson, Per LU
(2020)
In Clinical and Translational Radiation Oncology
24.
p.23-28
Mark
-
Erectile Dysfunction and Absorbed Dose to Penile Base Structures in a Randomized Trial Comparing Ultrahypofractionated and Conventionally Fractionated Radiation Therapy for Prostate Cancer
Rasmusson, Elisabeth LU ; Gunnlaugsson, Adalsteinn LU ; Wieslander, Elinore LU ; Höglund, Peter LU ; Widmark, Anders ; Fransson, Per ; Kjellén, Elisabeth LU and Nilsson, Per LU
(2020)
In International Journal of Radiation Oncology Biology Physics
107(1).
p.143-151
Mark
- Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma : the phase II PALAESTRA trial
- No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery : 20-Year Follow-up of the Randomized SweBCGRT Trial
- Substantial intrinsic variability in chemoradiosensitivity of newly established anaplastic thyroid cancer cell-lines
- 2019
- Distribution of Locoregional Breast Cancer Recurrence in Relation to Postoperative Radiation Fields and Biological Subtypes
- Comparative treatment planning study for mediastinal Hodgkin’s lymphoma : impact on normal tissue dose using deep inspiration breath hold proton and photon therapy